Technical Analysis for NVSEF - Novartis Ag Basl

Grade Last Price % Change Price Change
grade B 85.7 -0.23% -0.2000
NVSEF closed down 0.23 percent on Tuesday, April 7, 2020, on 28 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Up
Historical NVSEF trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Overbought Stochastic Strength 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.23%
Narrow Range Bar Range Contraction -0.23%
Gapped Up Strength -0.23%
Overbought Stochastic Strength -0.23%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 2.39%
Narrow Range Bar Range Contraction 2.39%
NR7 Range Contraction 2.39%
Stochastic Reached Overbought Strength 2.39%
Older signals for NVSEF ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company's Innovative Medicines segment offers patented prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology and dermatology, respiratory, cardio-metabolic, and established medicine products. The company's Sandoz segment provides active ingredients and finished dosage forms of pharmaceuticals in cardiovascular, central nervous system, dermatology, gastrointestinal and hormonal therapy, metabolism, oncology, ophthalmic, pain, and respiratory areas; and finished dosage form anti-infective. It also provides active pharmaceutical ingredients and intermediates primarily antibiotics; protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. The company's Alcon segment offers intraocular lenses and equipment for cataract procedures; equipment, instruments, and devices for vitreoretinal surgeries; surgical equipment and diagnostic devices for refractive surgical procedures; and devices to treat glaucoma. It also provides viscoelastics, surgical solutions, diagnostic ophthalmic products, surgical packs, and other disposable products for cataract and vitreoretinal surgery. In addition, this segment offers contact lenses and ocular health products; over-the-counter ophthalmic products; eye drops for the temporary relief of ocular itching due to allergies; vitamins for ocular health; and iLux Device, a therapeutic device used to treat meibomian gland dysfunction. Novartis AG has collaboration agreements with Xencor; Surface Oncology; Ligand Pharmaceuticals, Inc.; Amgen; University of California, Berkeley; Bristol-Myers Squibb; IBM Watson Health; Allergan plc; Science 37, Inc.; Bill & Melinda Gates Foundation; PEAR Therapeutics; Pfizer; and Conatus Pharmaceuticals Inc. The company was founded in 1895 and is headquartered in Basel, Switzerland.
Medicine Health Healthcare Biotechnology Pharmaceuticals Pain Pharmaceutical Industry In China Surgery Healthcare Products Healthcare Providers Neuroscience Active Pharmaceutical Ingredients Antibiotics Ophthalmology Glaucoma Allergies University Of California Cataract Diagnostic Devices Surgical Equipment Allergan Medicine Products Novartis Biotechnology Based Products Hormonal Therapy Melinda Gates Foundation Therapeutic Device

Is NVSEF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 98.0
52 Week Low 68.65
Average Volume 101,925
200-Day Moving Average 88.0244
50-Day Moving Average 86.4760
20-Day Moving Average 77.7292
10-Day Moving Average 79.4064
Average True Range 3.3066
ADX 24.02
+DI 33.2263
-DI 28.2249
Chandelier Exit (Long, 3 ATRs ) 77.2302
Chandelier Exit (Short, 3 ATRs ) 78.5698
Upper Bollinger Band 87.3936
Lower Bollinger Band 68.0648
Percent B (%b) 0.91
BandWidth 24.8668
MACD Line -0.5173
MACD Signal Line -2.3932
MACD Histogram 1.8759
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 87.8000
Resistance 3 (R3) 87.6333 86.7667 87.4500
Resistance 2 (R2) 86.7667 86.2319 86.8500 87.3332
Resistance 1 (R1) 86.2333 85.9015 85.8000 86.4000 87.2166
Pivot Point 85.3667 85.3667 85.1500 85.4500 85.3667
Support 1 (S1) 84.8333 84.8319 84.4000 85.0000 84.1834
Support 2 (S2) 83.9667 84.5015 84.0500 84.0668
Support 3 (S3) 83.4333 83.9667 83.9500
Support 4 (S4) 83.6000